Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia

Author:

Ramachandran Raja1,Bhargava Vinant2,Jasuja Sanjiv3ORCID,Gallieni Maurizio4ORCID,Jha Vivekanand5,Sahay Manisha6,Alexender Suceena7ORCID,Mostafi Mamun8,Pisharam Jayakrishnan K9,Chi Wai Tang Sydeny10,Jacob Chakko11,Gunawan Atma12,Leong Goh Bak13,Thwin Khin Thida14,Agrawal Rajendra Kumar15,Vareesangthip Kriengsak16,Tanchanco Roberto17,Choong Lina18,Herath Chula18,Lin Chih-Ching19,Cuong Nguyen The20,Akhtar Syed Fazal21,Alsahow Ali22,Rana D S23,Kher Vijay24,Rajapurkar M M25,Jeyaseelan L7,Puri Sonika26,Sagar Gaurav3,Bahl Anupam3,Verma Shalini27,Sethi Anil27,Vachharajani Tushar28

Affiliation:

1. PGIMER, Chandigarh, India

2. Sir Ganga Ram Hospital, India

3. Indraprastha Apollo Hospital, India

4. University of Milano, Italy

5. Executive Director, George Institute of Global Health, India

6. Osmania General Hospital, India

7. CMC, India

8. Department of Nephrology, Armed Forces Medical College, Bangladesh

9. Ministry of Health, Brunei, Darussalam Medical Services, Brunei

10. Department of Nephrology, Queen Mary Hospital, Hong Kong

11. Bangalore Baptist Hospital, India

12. Brawijaya University, Indonesia

13. Serdang Hospital, Malaysia

14. University Of Medicine, Myanmar

15. Department of Nephrology, Bir Hospital, Nepal

16. Nephrology Society of Thailand, Thailand

17. The Medical City, Philippine

18. Singapore General Hospital, Singapore

19. Taipei Veterans General Hospital

20. Department of Kidney diseases and Dialysis, Viet Duc University Hospital, Vietnam

21. Sindh Institute of Urology and Transplantation, Pakistan

22. Jahara Hospital, Kuwait

23. Sir Gangaram Hospital, India

24. Medanta Hospital Gurugram, India

25. Muljibhai Patel Urological Hospital, India

26. Rutgers Robert Wood Johnson Medical School, USA

27. AVATAR foundation, India

28. Cleveland Clinic, USA

Abstract

South and Southeast Asia is the most populated, heterogeneous part of the world. The Association of Vascular Access and InTerventionAl Renal physicians (AVATAR Foundation), India, gathered trends on epidemiology and Interventional Nephrology (IN) for this region. The countries were divided as upper-middle- and higher-income countries as Group-1 and lower and lower-middle-income countries as Group-2. Forty-three percent and 70% patients in the Group 1 and 2 countries had unplanned hemodialysis (HD) initiation. Among the incident HD patients, the dominant Vascular Access (VA) was non-tunneled central catheter (non-TCC) in 70% of Group 2 and tunneled central catheter (TCC) in 32.5% in Group 1 countries. Arterio-Venous Fistula (AVF) in the incident HD patients was observed in 24.5% and 35% of patients in Group-2 and Group-1, respectively. Eight percent and 68.7% of the prevalent HD patients in Group-2 and Group-1 received HD through an AVF respectively. Nephrologists performing any IN procedure were 90% and 60% in Group-2 and Group 1, respectively. The common procedures performed by nephrologists include renal biopsy (93.3%), peritoneal dialysis (PD) catheter insertion (80%), TCC (66.7%) and non-TCC (100%). Constraints for IN include lack of time (73.3%), lack of back-up (40%), lack of training (73.3%), economic issues (33.3%), medico-legal problems (46.6%), no incentive (20%), other interests (46.6%) and institution not supportive (26%). Routine VA surveillance is performed in 12.5% and 83.3% of Group-2 and Group-1, respectively. To conclude, non-TCC and TCC are the most common vascular access in incident HD patients in Group-2 and Group-1, respectively. Lack of training, back-up support and economic constraints were main constraints for IN growth in Group-2 countries.

Publisher

SAGE Publications

Subject

Nephrology,Surgery

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3